更多...
收起
This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
[中文简述(自动翻译):]  此基因是Myc家族的成员,并且编码蛋白质与碱性螺旋 - 环 - 螺旋(bHLH)结构域。该蛋白位于细胞核内,并且必须以结合DNA与另一个的bHLH蛋白质二聚化。该基因的扩增与多种肿瘤相关的,最显着的神经母细胞瘤。已发现该基因编码不同亚型多重选择性剪接转录变异体。 [由RefSeq的,2014年6月提供]
MYCN基因(以及对应的蛋白质)的细胞分布位置:
MYCN基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Oculodigitoesophagoduodenal syndrome | 0.481357209 | 7 | 6 | BeFree_CLINVAR_CTD_human_ORPHANET_UNIPROT |
Neuroblastoma | 0.333621751 | 708 | 2 | BeFree_CTD_human_LHGDN_ORPHANET |
Medulloblastoma | 0.129510397 | 26 | 0 | BeFree_CTD_human_LHGDN |
Neoplastic Cell Transformation | 0.12 | 1 | 0 | CTD_human |
Chromosome Aberrations | 0.12 | 1 | 0 | CTD_human |
Adenoid Cystic Carcinoma | 0.12 | 1 | 0 | CTD_human |
Hyperplasia | 0.12 | 1 | 0 | CTD_human |
Necrosis | 0.12 | 1 | 0 | CTD_human |
Neural crest tumor | 0.12 | 0 | 0 | ORPHANET |
Central neuroblastoma | 0.08 | 610 | 2 | BeFree |
Carcinogenesis | 0.010043349 | 37 | 1 | BeFree |
Retinoblastoma | 0.008967513 | 23 | 0 | BeFree_LHGDN |
Neoplasm Metastasis | 0.006514605 | 24 | 0 | BeFree |
Disseminated neuroblastoma | 0.006514605 | 24 | 0 | BeFree |
Tumor Progression | 0.005700279 | 21 | 0 | BeFree |
Nephroblastoma | 0.005081451 | 10 | 0 | BeFree_GAD |
Lymphoma | 0.00408156 | 5 | 0 | BeFree_LHGDN |
Stage 4S neuroblastoma | 0.003800186 | 14 | 0 | BeFree |
Brain Neoplasms | 0.003267234 | 2 | 0 | BeFree_LHGDN |
leukemia | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Neoplasm, Residual | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Sarcoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
synovial sarcoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Neurocytoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Congenital chromosomal disease | 0.002985861 | 11 | 0 | BeFree |
Basal cell carcinoma | 0.00272435 | 1 | 0 | LHGDN |
Small cell carcinoma of lung | 0.002714419 | 10 | 0 | BeFree |
Malignant Childhood Neoplasm | 0.002714419 | 10 | 0 | BeFree |
Rhabdomyosarcoma | 0.002442977 | 9 | 0 | BeFree |
Ganglioneuroblastoma | 0.002442977 | 9 | 0 | BeFree |
Kidney Neoplasm | 0.002367032 | 1 | 0 | GAD |
Ganglioneuroma | 0.002171535 | 8 | 0 | BeFree |
Alveolar rhabdomyosarcoma | 0.001628651 | 6 | 0 | BeFree |
stage, neuroblastoma | 0.001628651 | 6 | 0 | BeFree |
Glioblastoma | 0.001357209 | 5 | 0 | BeFree |
Neuroectodermal Tumor, Primitive | 0.001357209 | 5 | 0 | BeFree |
Malignant neoplasm of lung | 0.001357209 | 5 | 0 | BeFree |
Liver carcinoma | 0.001357209 | 5 | 0 | BeFree |
Colorectal Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Neuroectodermal Tumors | 0.001085767 | 4 | 0 | BeFree |
Triploidy syndrome | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of prostate | 0.001085767 | 4 | 2 | BeFree |
Prostate carcinoma | 0.001085767 | 4 | 2 | BeFree |
Colorectal Cancer | 0.001085767 | 4 | 0 | BeFree |
Trisomy | 0.000814326 | 3 | 0 | BeFree |
Rhabdomyosarcoma, Embryonal | 0.000814326 | 3 | 0 | BeFree |
Isochromosomes | 0.000814326 | 3 | 0 | BeFree |
Extraosseous Ewings sarcoma-primitive neuroepithelial tumor | 0.000814326 | 3 | 0 | BeFree |
Solid tumour | 0.000814326 | 3 | 0 | BeFree |
Neuroblastic Tumor | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Anaplasia | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of breast | 0.000542884 | 2 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.000542884 | 2 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.000542884 | 2 | 0 | BeFree |
Liver neoplasms | 0.000542884 | 2 | 0 | BeFree |
melanoma | 0.000542884 | 2 | 0 | BeFree |
Microcephaly | 0.000542884 | 2 | 0 | BeFree |
Embryonal Neoplasm | 0.000542884 | 2 | 0 | BeFree |
Neuroendocrine Tumors | 0.000542884 | 2 | 0 | BeFree |
Cervix carcinoma | 0.000542884 | 2 | 0 | BeFree |
Progressive Neoplastic Disease | 0.000542884 | 2 | 0 | BeFree |
Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of lung | 0.000542884 | 2 | 0 | BeFree |
Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000542884 | 2 | 0 | BeFree |
Chromosome 1, monosomy 1p | 0.000542884 | 2 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
Supratentorial Primitive Neuroectodermal Tumor | 0.000542884 | 2 | 0 | BeFree |
Ganglioneuroblastoma, Nodular | 0.000542884 | 2 | 0 | BeFree |
Xenograft Model | 0.000542884 | 2 | 0 | BeFree |
Progressive cGVHD | 0.000542884 | 2 | 0 | BeFree |
Abdominal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Adrenal Gland Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Rheumatoid Arthritis | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of urinary bladder | 0.000271442 | 1 | 0 | BeFree |
Malignant tumor of colon | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
Non-Small Cell Lung Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Ependymoma | 0.000271442 | 1 | 0 | BeFree |
Esophageal Atresia | 0.000271442 | 1 | 0 | BeFree |
Exanthema | 0.000271442 | 1 | 0 | BeFree |
Hepatitis | 0.000271442 | 1 | 0 | BeFree |
Hepatitis A | 0.000271442 | 1 | 0 | BeFree |
Lymphoid leukemia | 0.000271442 | 1 | 0 | BeFree |
Acute Megakaryocytic Leukemias | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of stomach | 0.000271442 | 1 | 0 | BeFree |
Meningioma | 0.000271442 | 1 | 0 | BeFree |
Mitral Valve Stenosis | 0.000271442 | 1 | 0 | BeFree |
Multiple Sclerosis | 0.000271442 | 1 | 0 | BeFree |
Nervous System Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Ovarian Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Pheochromocytoma | 0.000271442 | 1 | 0 | BeFree |
Temporomandibular Joint Dysfunction Syndrome | 0.000271442 | 1 | 0 | BeFree |
Attention Deficit Disorder | 0.000271442 | 1 | 0 | BeFree |
B-Cell Lymphomas | 0.000271442 | 1 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
Central Nervous System Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of testis | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
pineoblastoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Neuroendocrine | 0.000271442 | 1 | 0 | BeFree |
Central Neurocytoma | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.000271442 | 1 | 0 | BeFree |
Medullary carcinoma of thyroid | 0.000271442 | 1 | 0 | BeFree |
Spastic syndrome | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of colon stage IV | 0.000271442 | 1 | 0 | BeFree |
Medulloblastoma, Childhood | 0.000271442 | 1 | 0 | BeFree |
Gastric Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
childhood solid tumor | 0.000271442 | 1 | 0 | BeFree |
childhood synovial sarcoma | 0.000271442 | 1 | 0 | BeFree |
Anaplastic astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Retinoma | 0.000271442 | 1 | 0 | BeFree |
Opsoclonus-Myoclonus Syndrome | 0.000271442 | 1 | 0 | BeFree |
Thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
Ewings sarcoma | 0.000271442 | 1 | 0 | BeFree |
Malignant Glioma | 0.000271442 | 1 | 0 | BeFree |
Tumor Initiation | 0.000271442 | 1 | 0 | BeFree |
CNS metastases | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.000271442 | 1 | 0 | BeFree |
Stomach Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of bladder | 0.000271442 | 1 | 0 | BeFree |
Dissecting aneurysm of the thoracic aorta | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of kidney | 0.000271442 | 1 | 0 | BeFree |
Adult Acute Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Malignant Peripheral Nerve Sheath Tumor | 0.000271442 | 1 | 0 | BeFree |
Chromosome 10, monosomy 10q | 0.000271442 | 1 | 0 | BeFree |
Localized Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Spots on skin | 0.000271442 | 1 | 0 | BeFree |
Advanced cancer | 0.000271442 | 1 | 0 | BeFree |
precancerous lesions | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of ovary | 0.000271442 | 1 | 0 | BeFree |
Attention deficit hyperactivity disorder | 0.000271442 | 1 | 0 | BeFree |
Atypical teratoid/rhabdoid tumor | 0.000271442 | 1 | 0 | BeFree |
Retinoblastoma, spontaneously regressed | 0.000271442 | 1 | 0 | BeFree |
Anaplastic large B-cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
Localized Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Stage 3 Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Testicular Germ Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Renal carcinoma | 0.000271442 | 1 | 0 | BeFree |
Desmoplastic | 0.000271442 | 1 | 0 | BeFree |
Differentiating Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Poorly Differentiated Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Ganglioneuroblastoma, Intermixed | 0.000271442 | 1 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
TIBIAL MUSCULAR DYSTROPHY, TARDIVE | 0.000271442 | 1 | 0 | BeFree |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。